Khan Jamal Azfar, Satti Luqman, Bizanjo Mahwash, Ather Nadia A
Internal Medicine, Pakistan Navy Ship Shifa Hospital, Bahria University Medical & Dental College, Karachi, PAK.
Medical Microbiology, Pakistan Navy Ship Shifa Hospital, Bahria University Medical & Dental College, Karachi, PAK.
Cureus. 2022 Apr 1;14(4):e23726. doi: 10.7759/cureus.23726. eCollection 2022 Apr.
Introduction In Pakistan, the fourth wave of coronavirus disease 2019 (Covid-19) started around July 2021, which was dominated by the Delta variant of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus. The vaccination drive to immunize the people of Pakistan against Covid-19 was also going on during this period. There were multiple types of vaccines being administered to the people of Pakistan, as the vaccines had been procured from multiple sources. Some people had apprehensions about different vaccines being administered in the country. The purpose of this study was to compare the clinical characteristics and outcome of the patients vaccinated against Covid-19 with those of the non-vaccinated patients during the fourth wave of Covid-19 in Pakistan Naval Ship (PNS) Shifa Hospital. Methods The cross-sectional descriptive study was performed at PNS Shifa Hospital Karachi, from July to October 2021. All the Covid-19 patients treated in PNS Shifa Hospital during the "fourth Covid-19 wave" were interviewed. Their medical records were accessed, and they were followed up till their discharge from the hospital. The vaccinated and non-vaccinated patients were compared for differences in their age or gender distribution, the severity of illness, comorbidities, and mortality. Results There were 884 participants in the study: 664 (75.11%) men and 220 (24.89%) women. There were 493 patients below 40 years of age, 233 were 40-59 years old, and 158 were aged 60 and above. One hundred and sixty-nine patients had one or more comorbidities, including hypertension, diabetes mellitus, ischemic heart disease, various malignancies, bronchial asthma, and chronic kidney disease. There were 63 (7.13%) obese patients, 28 of whom developed severe disease. Five hundred and four (57%) patients were vaccinated and 380 (47%) were non-vaccinated. Among the vaccinated patients, the effect of Covid-19 was mild in 58.37%, moderate in 36.11%, severe in 0.79%, and critical in 4.37%. Among the non-vaccinated patients, the effect of Covid-19 was mild in 40.26%, moderate in 46.58%, severe in 3.16%, and critical in 10%. The difference in disease severity between the two groups was statistically significant (<0.05). Conclusion Vaccinated Covid-19 patients had significantly lower severity of disease and displayed better outcomes when compared to non-vaccinated patients during the fourth Covid-19 wave dominated by the Delta variant of the SARS-CoV-2 virus.
引言
在巴基斯坦,2019年冠状病毒病(Covid-19)的第四波疫情始于2021年7月左右,该波疫情以严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的德尔塔变种为主导。在此期间,巴基斯坦也在开展针对民众的Covid-19疫苗接种工作。由于疫苗是从多个来源采购的,因此有多种类型的疫苗被用于巴基斯坦民众。一些人对该国使用的不同疫苗存在担忧。本研究的目的是比较在巴基斯坦海军舰艇(PNS)希法医院Covid-19第四波疫情期间接种Covid-19疫苗的患者与未接种疫苗的患者的临床特征和结局。
方法
本横断面描述性研究于2021年7月至10月在卡拉奇的PNS希法医院进行。对在“Covid-19第四波疫情”期间在PNS希法医院接受治疗的所有Covid-19患者进行了访谈。查阅了他们的病历,并对他们进行随访直至出院。比较接种疫苗和未接种疫苗的患者在年龄或性别分布、疾病严重程度、合并症和死亡率方面的差异。
结果
本研究共有884名参与者:男性664名(75.11%),女性220名(24.89%)。年龄在40岁以下的患者有493名,40 - 59岁的有233名,60岁及以上的有158名。169名患者有一种或多种合并症,包括高血压、糖尿病、缺血性心脏病、各种恶性肿瘤、支气管哮喘和慢性肾脏病。有63名(7.13%)肥胖患者,其中28名发展为重症。504名(57%)患者接种了疫苗,380名(47%)未接种疫苗。在接种疫苗的患者中,Covid-19的影响为轻度的占58.37%,中度的占36.11%,重度的占0.79%,危重症的占4.37%。在未接种疫苗的患者中,Covid-19的影响为轻度的占40.26%,中度的占46.58%,重度的占3.16%,危重症的占10%。两组之间疾病严重程度的差异具有统计学意义(<0.05)。
结论
在由SARS-CoV-2病毒的德尔塔变种主导的Covid-19第四波疫情期间,与未接种疫苗的患者相比,接种Covid-19疫苗的患者疾病严重程度显著更低,且结局更好。